Distribution and Clinical Analysis of EpCAM+/Vimentin+ Circulating Tumor Cells in High-Risk Population and Cancer Patients
Circulating Tumor Cells (CTCs) are already present in the peripheral blood of patients with early tumors and even precancerous lesions. The objective of this study was to determine the count of CTCs in peripheral blood from high-risk population(HRP), healthy subjects and patients with Pan-cancer. Th...
Main Authors: | Chunjin Huang, Sheng Ding, Chunyan Huang, Feng Pan, Xiaodong Liu, Haijiao Zhang, Jian Zhou, Xiaofei Liang, Xinyan Wang, Ping Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.642971/full |
Similar Items
-
Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study
by: Yang Gao, et al.
Published: (2021-03-01) -
EpCAM as Modulator of Tissue Plasticity
by: François Fagotto
Published: (2020-09-01) -
Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition
by: Taylor C. Brown, et al.
Published: (2021-06-01) -
Circulating Tumor Cell Detection In Epithelial Ovarian Cancer Using Dual-Component Antibodies Targeting EpCAM And FRα
by: Li N, et al.
Published: (2020-01-01) -
EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM
by: Warangkana Chantima, et al.
Published: (2017-12-01)